<DOC>
	<DOCNO>NCT00170326</DOCNO>
	<brief_summary>The purpose pilot study evaluate progression ventricular dysfunction patient ventricular dysfunction within permanent pace population .</brief_summary>
	<brief_title>Progressive Ventricular Dysfunction Prevention Pacemaker Patients</brief_title>
	<detailed_description>The interventricular synchrony one component proper cardiac function . When synchrony -as leave bundle block ( LBBB ) - clinic consequence little importance patient healthy heart great importance patient suffer heart failure ( HF ) , specially severe grade HF , benefit cardiac resynchronization pace ventricle leave ventricle ( LV ) mean healthy improvement patient . All previous study do HF , patient symptomatic HF . The importance stop progression latent HF patient asymptomatic ventricular dysfunction ( VD ) permanent pace indication patient . Pacing may accelerate HF progression dissincronyzing ventricle . ACE inhibitor study asymptomatic VD give positive result . The PreVent-HF international , multicenter , prospective , randomize , single-blinded pilot trial specifically design evaluate main objective progression VD permanent pace population .</detailed_description>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<criteria>Meet Class I and/or Class IIa implantation criterion permanent cardiac pacing accord guideline give American College Cardiology ( ACC ) /American Heart Association ( AHA ) . Expected ventricle stimulation &lt; 80 % time Impossibility dual chamber stimulation absence AF Severe heart failure ( NYHA Functional class IIIIV ) previous indication pace device implant Patient need revascularization within 3 month Myocardial infarction last 3 month Cardiac surgery perform last 3 month Hypertrophic cardiomyopathy Constrictive pericarditis Bad echo window Previous system implant ( ICD pacemaker ) Aortic stenosis Patient mechanical right heart valve Patient &lt; 18 year Pregnancy Patient medical condition would preclude test require protocol , limit study participation Life expectancy &lt; 1year Patient unwilling unable cooperate give write informed consent . Patient inaccessible followup study center . Patients participate plan participate clinical trial clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Permanent Pacing artificial internal</keyword>
</DOC>